STORM Therapeutics a spin out from the Gurdon Institute at the University of Cambridge is translating the ground-breaking work of its two founders, Professors Tony Kouzarides and Eric Miska in RNA epigenetics into the discovery of first-in-class drugs in oncology and other diseases.
Established by Tony Kouzarides and Eric Miska the first international STORM Therapeutics Conference on RNA epigenetics in human disease will be held at St Catharine’s College in Cambridge, UK from 17- September 2019.
Our appreciation of the biology of RNA epigenetics is progressing at an incredible pace. With ~150 RNA modifications known RNA epigenetics opens new perspectives on RNA and its regulation, far surpassing the complexity of histone modification.
RNA epigenetics is an emerging area of drug discovery and is key to understanding human disease providing new diagnostic and therapeutic opportunities.
The RNA epigenetics in human disease conference 2019 is the first of a series of events organised by STORM Therapeutics in this exciting area of science.